These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9272819)

  • 1. Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMDA receptor.
    Eide PK; Stubhaug A; Breivik H; Oye I
    Pain; 1997 Aug; 72(1-2):289-91. PubMed ID: 9272819
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine: relief from chronic pain through actions at the NMDA receptor?
    Meller ST
    Pain; 1996 Dec; 68(2-3):435-6. PubMed ID: 9121834
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketamine analgesia, NMDA receptors and the gates of perception.
    Oye I
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):747-9. PubMed ID: 9698947
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
    Hillhouse TM; Negus SS
    Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor antagonists and pain: ketamine.
    Muir WW
    Vet Clin North Am Equine Pract; 2010 Dec; 26(3):565-78. PubMed ID: 21056300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of chronic neuropathic pain with the NMDA (N-methyl-D-aspartate) receptor antagonist ketamine.
    Stubhaug A; Breivik H
    Acta Anaesthesiol Scand; 1997 Mar; 41(3):329-31. PubMed ID: 9113174
    [No Abstract]   [Full Text] [Related]  

  • 10. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade.
    Eide PK; Stubhaug A
    Neurosurgery; 1997 Aug; 41(2):505-8. PubMed ID: 9257324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
    Danilova EI; Grafova VN; Reshetniak VK
    Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the use of ketamine in pain management.
    Tawfic QA
    J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of excitatory amino acid antagonists in pain management.
    Wong CS; Cherng CH; Ho ST
    Acta Anaesthesiol Sin; 1995 Dec; 33(4):227-32. PubMed ID: 8705156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain.
    De Kock MF; Lavand'homme PM
    Best Pract Res Clin Anaesthesiol; 2007 Mar; 21(1):85-98. PubMed ID: 17489221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of norketamine enantiomers in rodent models of persistent pain.
    Holtman JR; Crooks PA; Johnson-Hardy JK; Hojomat M; Kleven M; Wala EP
    Pharmacol Biochem Behav; 2008 Oct; 90(4):676-85. PubMed ID: 18586315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor blockade prevents nitroglycerin-induced headaches.
    Roffey P; Mikhail M; Thangathurai D
    Headache; 2001; 41(7):733. PubMed ID: 11554966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.